Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary
disease (COPD) without effective drugs to treat. We conducted a systematic review and meta …

Some patients with chronic obstructive pulmonary disease (COPD) have pulmonary
hypertension (PH) that adversely affects survival. We performed a systematic review and …

Aims Pulmonary hypertension (PH) is a severe and prevalent complication of chronic
obstructive pulmonary disease (COPD), with low quality of life and poor prognosis. This …

Chronic obstructive pulmonary disease-associated pulmonary hypertension (COPD-PH) is
an increasingly recognised condition which contributes to worsening dyspnoea and poor …

Background: There is no recommendation for treating pulmonary hypertension (PH) when
associated with chronic obstructive pulmonary disease (COPD). Objective: To evaluate the …

Purpose Pulmonary hypertension (PH) due to COPD has dismal prognosis. We reviewed
the long-term effect of PH-target therapy in severe PH-COPD. Method Patients attending our …

Endothelin receptor antagonists, phosphodiesterase (PDE)-5 inhibitors and prostanoids are
effective treatments for pulmonary arterial hypertension (PAH), a severe but relatively rare …

Pulmonary hypertension is a serious complication of chronic obstructive pulmonary disease
(COPD) that currently has no established pharmacological treatment. This study aimed to …

Background Pulmonary hypertension (PH) is a frequent complication in patients with COPD.
Objective To determine if, in patients with COPD, the presence of PH decreases exercise …

Background Pulmonary hypertension (PH) in COPD is a poorly investigated clinical
condition. Research Question Which factors determine the outcome of PH in COPD? Study …